Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Angiology
Endovascular brachytherapy for prophylaxis after femoropopliteal angioplasty is studied
October 25th, 2006
Percutaneous transluminal angioplasty (PTA) followed by gamma radiation endovascular brachytherapy (EBT) resulted in a delay but not an inhibition of restenosis when compared to PTA alone. Investigators in Austria conducted a study "to report the 5-year results from the prospective randomized Vienna-2 trial, which was designed to evaluate the safety and effectiveness of adjunctive EBT compared with no further treatment after successful revascularization in patients with long-segment femoropopliteal lesions. Each patient gave written informed consent to participate in the study, which was approved by the hospital's ethics committee." R.M. Wolfram and...
Source: Biotech Week (2006-10-25)
|
